HT
MDCO

HAP Trading’s Medicines Co MDCO Stock Holding History

HAP Trading’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-250,200
Closed -$287K – 1597
2019
Q3 		$287K Buy
250,200
+190,100
+316% +$7.58M 0.02% 426
2019
Q2 		$117K Sell
60,100
-338,700
-85% -$11.1M 0.01% 581
2019
Q1 		$1.43M Buy
+398,800
New +$9.4M 0.13% 144
2017
Q4 		– Sell
-11,500
Closed -$114K – 1233
2017
Q3 		$114K Sell
11,500
-147,100
-93% -$5.42M 0.01% 564
2017
Q2 		$675K Buy
158,600
+109,700
+224% +$4.89M 0.04% 317
2017
Q1 		$161K Buy
48,900
+14,000
+40% +$639K 0.01% 507
2016
Q4 		$84K Sell
34,900
-175,900
-83% -$6.24M ﹤0.01% 590
2016
Q3 		$85K Buy
210,800
+20,800
+11% +$784K ﹤0.01% 614
2016
Q2 		$228K Buy
+190,000
New +$6.7M 0.01% 419
2015
Q3 		– Sell
-95,000
Closed -$29K – 1249
2015
Q2 		$29K Buy
95,000
+5,000
+6% +$139K ﹤0.01% 738
2015
Q1 		$106K Buy
+90,000
New +$2.53M 0.01% 527

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

HAP Trading's MDCO Position: Q1 2020 in Review

HAP Trading sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 56,257 shares — an estimated $4.78M sold.

HAP Trading first reported a position in MDCO in Q1 2015 and held it in 7 quarters. The position peaked at $4.78M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • HAP Trading reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • HAP Trading sold 56,257 Medicines Co shares in Q1 2020, an estimated $4.78M.
  • HAP Trading first reported a position in Medicines Co in Q1 2015 and held it in 7 quarters.
  • HAP Trading's Medicines Co position peaked at $4.78M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on HAP Trading's 13F filing for Q1 2020, filed 8 May 2020.